These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 28167400

  • 21. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
    Salameh H, Abu Omar M, Alhariri A, Kisra S, Qasem A, Abdulhak AB.
    Am J Ther; 2016; 23(4):e1110-5. PubMed ID: 25486517
    [Abstract] [Full Text] [Related]

  • 22. Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab.
    Chonat S, Chandrakasan S, Kalinyak KA, Ingala D, Gruppo R, Kalfa TA.
    Br J Haematol; 2016 Nov; 175(4):744-747. PubMed ID: 27870017
    [No Abstract] [Full Text] [Related]

  • 23. Autoimmune-type atypical hemolytic uremic syndrome treated with eculizumab as first-line therapy.
    Hisano M, Ashida A, Nakano E, Suehiro M, Yoshida Y, Matsumoto M, Miyata T, Fujimura Y, Hattori M.
    Pediatr Int; 2015 Apr; 57(2):313-7. PubMed ID: 25868950
    [Abstract] [Full Text] [Related]

  • 24. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.
    Clin Nephrol; 2015 Sep; 84(3):181-5. PubMed ID: 25816809
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A.
    Transfus Apher Sci; 2016 Dec; 55(3):357-362. PubMed ID: 27742267
    [Abstract] [Full Text] [Related]

  • 26. ATYPICAL HEMOLYTIC UREMIC SYNDROME IN AN ADULT SUCCESSFULLY TREATED WITH ECULIZUMAB.
    Chaudoir C, Ong MG, Gu X, Veillon D, Cotelingam J.
    J La State Med Soc; 2016 Dec; 168(1):12-5. PubMed ID: 26986861
    [Abstract] [Full Text] [Related]

  • 27. Atypical hemolytic-uremic syndrome.
    Kaartinen K, Martola L, Meri S.
    Duodecim; 2017 Dec; 133(6):539-47. PubMed ID: 29243465
    [Abstract] [Full Text] [Related]

  • 28. Atypical hemolytic uremic syndrome due to DGKE mutation and response to eculizumab: lessons for the clinical nephrologist.
    Husain D, Barron B, Barron AG, Sandokji I, Marsenic O, Warejko JK.
    J Nephrol; 2021 Aug; 34(4):1331-1335. PubMed ID: 33751496
    [No Abstract] [Full Text] [Related]

  • 29. [Diagnostic and Therapeutic Challenges in Atypical Hemolytic Uremic Syndrome: A Case Report].
    Reis S, Ramos D, Cordinhã C, Gomes C.
    Acta Med Port; 2019 Oct 01; 32(10):673-675. PubMed ID: 31625881
    [Abstract] [Full Text] [Related]

  • 30. Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab.
    Vakiti A, Singh D, Pilla R, Alhaj-Moustafa M, Fitzpatrick KW.
    J Oncol Pharm Pract; 2019 Jun 01; 25(4):1011-1015. PubMed ID: 29768958
    [Abstract] [Full Text] [Related]

  • 31. Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.
    Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.
    J Am Soc Nephrol; 2019 Dec 01; 30(12):2449-2463. PubMed ID: 31575699
    [Abstract] [Full Text] [Related]

  • 32. Long-term remission with eculizumab in atypical haemolytic uraemic syndrome.
    Carter S, Hewitt I, Kausman J.
    Nephrology (Carlton); 2017 Feb 01; 22 Suppl 1():7-10. PubMed ID: 28176479
    [Abstract] [Full Text] [Related]

  • 33. Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H.
    Madden I, Roumenina LT, Langlois-Meurinne H, Guichoux J, Llanas B, Frémeaux-Bacchi V, Harambat J, Godron-Dubrasquet A.
    Pediatr Nephrol; 2019 Mar 01; 34(3):533-537. PubMed ID: 30560448
    [Abstract] [Full Text] [Related]

  • 34. Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome.
    Mussoni MP, Veneziano FA, Boetti L, Tassi C, Calisesi C, Nucci S, Rigotti A, Panzini I, Ardissino G.
    Transfus Apher Sci; 2014 Oct 01; 51(2):134-6. PubMed ID: 25294113
    [Abstract] [Full Text] [Related]

  • 35. Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS).
    Santangelo L, Netti GS, Mazza S, Zito F, Catalano V, Martino M, Torres DD, Carbone V, Ranieri E, Giordano M.
    Indian J Pediatr; 2024 Feb 01; 91(2):205. PubMed ID: 37776486
    [No Abstract] [Full Text] [Related]

  • 36. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.
    Clin Exp Nephrol; 2019 Jan 01; 23(1):65-75. PubMed ID: 29959568
    [Abstract] [Full Text] [Related]

  • 37. A 'silent', new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantation.
    Broeders EN, Stordeur P, Rorive S, Dahan K.
    BMJ Case Rep; 2014 Dec 23; 2014():. PubMed ID: 25538218
    [Abstract] [Full Text] [Related]

  • 38. Renal failure, respiratory distress, and an atypical purpuric rash in a full-term infant with omphalocele and hypospadias: Answers.
    Weiss AJ, Kronforst K.
    Pediatr Nephrol; 2019 Nov 23; 34(11):2339-2342. PubMed ID: 31236666
    [No Abstract] [Full Text] [Related]

  • 39. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr 23; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 40. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.
    Clin Exp Nephrol; 2019 Jan 23; 23(1):112-121. PubMed ID: 30039480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.